Skip to main content
OpenTrials
Completed

NCT Number: NCT02717234

Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement

To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
  • Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
  • Willing to provide signed informed consent

Exclusion criteria

  • Smoker
  • Patients with potential for non-compliance
  • Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
  • Subject who in the Investigator's assessment cannot be expected to comply with study protocol
  • Currently participating in another conflicting clinical trial.

Treatment and study plan

Oral Nutrition Supplement

Other

Oral nutrition supplement intended for consumption at 3 servings per day

Primary outcomes

  1. Change in plasma arginine levels in µmol/L

    Time frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

Secondary outcomes

  1. Change in plasma-free phospholipid Eicosapentaenoic acid (EPA) in µg/ml

    Time frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

  2. Change in plasma phospholipid Eicosapentaenoic acid (EPA) in µg/ml

    Time frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

Other outcomes

  1. Change in plasma-free phospholipid Docosahexaenoic acid (DHA) in µg/ml

    Time frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

  2. Change in plasma phospholipid Docosahexaenoic acid (DHA) in µg/ml

    Time frame: Pre-consumption, 30, 60, 120, 180, 240 minutes

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 23, 2016
Registry last updated
May 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.